ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Boston, MA, USA:

Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer

and radiation therapy in people with microsatellite stable pancreatic cancer.The names of the study interventions involved in this ...

Active, not recruiting
Metastatic Pancreatic Cancer
Pancreatic Cancer
Drug: Ipilimumab
Drug: Nivolumab

Phase 2

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States and 2 other locations

This research study is studying an investigational therapy as a possible treatment for pancreatic cancer.The drugs involved in this...

Active, not recruiting
Pancreatic Cancer
Drug: Niraparib

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 2 other locations

receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...

Active, not recruiting
Pancreatic Cancer
Radiation: Stereotactic MRI-guided On-table Adaptive Radiation Therapy
Viewray

Boston, Massachusetts, United States and 12 other locations

This research study is studying a combination of drugs with radiation therapy as a possible treatment for Microsatellite Stable Colorectal Cancer...

Enrolling
Microsatellite Stable Colorectal Cancer
MSI High Colorectal Cancer
Drug: Nivolumab
Radiation: Radiation Therapy

Phase 2

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States

This research study is studying a combination of interventions as a possible treatment for pancreatic tumor.The interventions involved in th...

Active, not recruiting
Pancreatic Cancer
Drug: Nivolumab
Drug: FOLFIRINOX

Phase 2

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States and 9 other locations

with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...

Active, not recruiting
Pancreatic Cancer Non-resectable
Drug: Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX
Drug: Placebo + Gemcitabine + Nab-paclitaxel or Placebo + FOLFIRINOX

Phase 3

FibroGen
FibroGen

Worcester, Massachusetts, United States of America and 89 other locations

Multicenter, double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of anamorelin HCl. Approximately 100 subjects wit...

Enrolling
Metastatic Pancreatic Cancer
Drug: Placebo
Drug: Anamorelin Hydrochloride

Phase 2

Lahey Health
Lahey Health

Burlington, Massachusetts, United States

This study is being done to test the safety and effectiveness of combining ZN-c3 and Gemcitabine in participants with pancreatic cancer...

Enrolling
Pancreatic Ductal Adenocarcinoma
Advanced Pancreatic Adenocarcinoma
Drug: Gemzar
Drug: Zentalis

Phase 2

Brandon Huffman

Boston, Massachusetts, United States

This study is being done to test the safety and effectiveness of combining domvanalimab (AB154), zimberelimab (AB122), and APX005M with pancreatic...

Enrolling
Pancreatic Cancer
Squamous Cell Carcinoma of Pancreas
Drug: DOMVANALIMAB
Drug: ZIMBERELIMAB

Phase 1, Phase 2

James Cleary, MD, PhD

Boston, Massachusetts, United States

in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreat...

Enrolling
Metastatic Cancer
Neoplasms Pancreatic
Drug: avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel

Phase 1, Phase 2

Verastem

Boston, Massachusetts, United States and 10 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems